A therapy that targets a mutation in a critical tumor suppressor gene exhibited “impressive” activity in a cohort of heavily ...
The study of mutant p53 isoforms lies at the forefront of cancer biology, revealing the profound impact of TP53 gene alterations on tumor progression and ...
Prevention of Cisplatin-Induced Emesis by the Oral Neurokinin-1 Antagonist, MK-869, in Combination With Granisetron and Dexamethasone or With Dexamethasone Alone PURPOSE: To study the additional ...
Lamassu Bio Inc. has been awarded a $2.05 million grant from the NIH and National Cancer Institute (NCI) for the development of SA-53 as a treatment for p53 wild-type sarcomas. SA-53 is designed to ...
Detailed price information for Pmv Pharmaceuticals Inc (PMVP-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results